BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19706044)

  • 1. Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.
    Nikpour P; Mowla SJ; Jafarnejad SM; Fischer U; Schulz WA
    Cell Prolif; 2009 Dec; 42(6):762-9. PubMed ID: 19706044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knocking-down the expression of nucleostemin significantly decreases rate of proliferation of rat bone marrow stromal stem cells in an apparently p53-independent manner.
    Jafarnejad SM; Mowla SJ; Matin MM
    Cell Prolif; 2008 Feb; 41(1):28-35. PubMed ID: 18211284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells.
    Sijin L; Ziwei C; Yajun L; Meiyu D; Hongwei Z; Guofa H; Siguo L; Hong G; Zhihong Z; Xiaolei L; Yingyun W; Yan X; Weide L
    J Exp Clin Cancer Res; 2004 Sep; 23(3):529-38. PubMed ID: 15595646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro study of nucleostemin as a potential therapeutic target in human breast carcinoma SKBR-3 cells.
    Guo Y; Liao YP; Zhang D; Xu LS; Li N; Guan WJ; Liu CQ
    Asian Pac J Cancer Prev; 2014; 15(5):2291-5. PubMed ID: 24716972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of nucleostemin in the maintenance of nucleolar architecture and integrity of small nucleolar ribonucleoproteins and the telomerase complex.
    Romanova L; Kellner S; Katoku-Kikyo N; Kikyo N
    J Biol Chem; 2009 Sep; 284(39):26685-94. PubMed ID: 19648109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
    Rahmati M; Moosavi MA; Zarghami N
    Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
    Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.
    Yuan F; Cheng Q; Li G; Tong T
    PLoS One; 2015; 10(10):e0141678. PubMed ID: 26517370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of phospholipase C-epsilon by short-hairpin RNA-mediated gene silencing induces apoptosis in human bladder cancer cell lines.
    Zhang Y; Yan L; Zhao Y; Ou L; Wu X; Luo C
    Cancer Biother Radiopharm; 2013 Apr; 28(3):233-9. PubMed ID: 23484808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway.
    Ma H; Pederson T
    Mol Biol Cell; 2007 Jul; 18(7):2630-5. PubMed ID: 17494866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of nucleostemin can inhibit the proliferation of esophageal carcinoma cells in vitro through upregulating p21.
    Sun Y; Tan X; Tang Z; Peng G; Yang S; Wang R; Lan C; Chen D; Fang D
    Hepatogastroenterology; 2014; 61(136):2247-52. PubMed ID: 25699361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-mitotic role of nucleostemin as a promoter of skeletal muscle cell differentiation.
    Hirai H; Romanova L; Kellner S; Verma M; Rayner S; Asakura A; Kikyo N
    Biochem Biophys Res Commun; 2010 Jan; 391(1):299-304. PubMed ID: 19914205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleostemin exerts anti-apoptotic function via p53 signaling pathway in cardiomyocytes.
    Zhang C; Shi J; Qian L; Zhang C; Wu K; Yang C; Yan D; Wu X; Liu X
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1064-71. PubMed ID: 26138242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors.
    Malakootian M; Mowla SJ; Saberi H; Asadi MH; Atlasi Y; Shafaroudi AM
    Mol Carcinog; 2010 Sep; 49(9):818-25. PubMed ID: 20572164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continual expression throughout the cell cycle and downregulation upon adipogenic differentiation makes nucleostemin a vital human MSC proliferation marker.
    Oktar PA; Yildirim S; Balci D; Can A
    Stem Cell Rev Rep; 2011 Jun; 7(2):413-24. PubMed ID: 21063916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
    Dai MS; Sun XX; Lu H
    Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleostemin mRNA is expressed in both normal and malignant renal tissues.
    Fan Y; Liu Z; Zhao S; Lou F; Nilsson S; Ekman P; Xu D; Fang X
    Br J Cancer; 2006 Jun; 94(11):1658-62. PubMed ID: 16670719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin is a binding partner of nucleostemin in human osteosarcoma cells.
    Ma H; Pederson T
    Mol Biol Cell; 2008 Jul; 19(7):2870-5. PubMed ID: 18448670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.